- Home
- FIBK vs ARWR Comparison
FIBK vs ARWR Comparison
Compare FIBK & ARWR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FIBK
- ARWR
- Stock Information
- Founded
- FIBK 1879
- ARWR 2003
- Country
- FIBK United States
- ARWR United States
- Employees
- FIBK N/A
- ARWR N/A
- Industry
- FIBK Major Banks
- ARWR Biotechnology: Pharmaceutical Preparations
- Sector
- FIBK Finance
- ARWR Health Care
- Exchange
- FIBK Nasdaq
- ARWR Nasdaq
- Market Cap
- FIBK 2.6B
- ARWR 2.5B
- IPO Year
- FIBK 2010
- ARWR 1993
- Fundamental
- Price
- FIBK $32.68
- ARWR $29.72
- Analyst Decision
- FIBK Buy
- ARWR Strong Buy
- Analyst Count
- FIBK 7
- ARWR 8
- Target Price
- FIBK $34.57
- ARWR $47.75
- AVG Volume (30 Days)
- FIBK 759.2K
- ARWR 2.9M
- Earning Date
- FIBK 10-23-2025
- ARWR 08-07-2025
- Dividend Yield
- FIBK 5.72%
- ARWR N/A
- EPS Growth
- FIBK N/A
- ARWR N/A
- EPS
- FIBK 2.22
- ARWR N/A
- Revenue
- FIBK $935,300,000.00
- ARWR $572,976,000.00
- Revenue This Year
- FIBK $10.42
- ARWR $22,306.37
- Revenue Next Year
- FIBK $3.69
- ARWR N/A
- P/E Ratio
- FIBK $14.81
- ARWR N/A
- Revenue Growth
- FIBK N/A
- ARWR 2816.20
- 52 Week Low
- FIBK $22.95
- ARWR $9.57
- 52 Week High
- FIBK $36.77
- ARWR $31.13
- Technical
- Relative Strength Index (RSI)
- FIBK 62.03
- ARWR 76.98
- Support Level
- FIBK $32.00
- ARWR $27.10
- Resistance Level
- FIBK $32.99
- ARWR $29.34
- Average True Range (ATR)
- FIBK 0.58
- ARWR 1.47
- MACD
- FIBK -0.02
- ARWR 0.47
- Stochastic Oscillator
- FIBK 64.60
- ARWR 86.89
About FIBK First Interstate BancSystem Inc. (DE)
First Interstate BancSystem Inc is a financial holding company. It is the parent company of First Interstate Bank, a community bank offering a range of internet, mobile, and other banking and financial services throughout Idaho, Montana, Oregon, South Dakota, Washington, and Wyoming. It delivers a range of financial products and services to both retail and commercial customers in industries like agriculture, construction, education, energy, governmental services, healthcare, mining, professional services, retail, tourism, and wholesale trade. It generates majority of income from interest charged on loans, and interest and dividends earned on investments.
About ARWR Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting cardiovascular, Cardiometabolic, Central Nervous System, Pulmonary, Liver, Muscular, and Complement Mediated Disease. It majority products are liver disease curable.